Shares of Arcutis Biotherapeutics, Inc. (ARQT) have gained 34.5% over the past four weeks to close the last trading session at $11.51, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.43 indicates a potential upside of 60.1%.The average comprises seven short-term price targets ranging from a low of $11 to a high of $26, with a standard deviation of $4.50. While the lowest est ...

Shares of FuelCell Energy (FCEL) have gained 4.6% over the past four weeks to close the last trading session at $10.70, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $29.61 indicates a potential upside of 176.7%.The average comprises six short-term price targets ranging from a low of $5 to a high of $60.06, with a standard deviation of $21.26. While the lowest estimate indicat ...

Shares of Dynavax Technologies (DVAX) have gained 7.2% over the past four weeks to close the last trading session at $12.66, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $24.50 indicates a potential upside of 93.5%.The mean estimate comprises four short-term price targets with a standard deviation of $6.61. While the lowest estimate of $15 indicates an 18.5% increase from the ...

Shares of NexGen Energy (NXE) have gained 10.8% over the past four weeks to close the last trading session at $8.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $10.47 indicates a potential upside of 26%.The mean estimate comprises 11 short-term price targets with a standard deviation of $1.79. While the lowest estimate of $8.76 indicates a 5.4% increase from the current pri ...

Shares of Sarepta Therapeutics (SRPT) have gained 0.2% over the past four weeks to close the last trading session at $130.50, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $185.45 indicates a potential upside of 42.1%.The mean estimate comprises 20 short-term price targets with a standard deviation of $31.14. While the lowest estimate of $80 indicates a 38.7% decline from the ...

Strategic Education (STRA) closed the last trading session at $98.92, gaining 13.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $126.67 indicates a 28.1% upside potential.The average comprises three short-term price targets ranging from a low of $120 to a high of $135, with a standard deviation of $7.64. While the lowest estimate indicates an increase of 21.3% from the current ...

ReNew Energy Global PLC (RNW) closed the last trading session at $6.05, gaining 5.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.61 indicates a 42.3% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $1.06. While the lowest estimate of $7.31 indicates a 20.8% increase from the current price level, the most optimistic analy ...

Townsquare Media (TSQ) closed the last trading session at $10.13, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $16.83 indicates a 66.1% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $4.25. While the lowest estimate of $12.50 indicates a 23.4% increase from the current price level, the most optimistic analyst ...

Shares of Poseida Therapeutics, Inc. (PSTX) have gained 282.9% over the past four weeks to close the last trading session at $9.38, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14 indicates a potential upside of 49.3%.The mean estimate comprises three short-term price targets with a standard deviation of $5.29. While the lowest estimate of $10 indicates a 6.6% increase from ...

HP Inc. (HPQ) reported fourth-quarter fiscal 2024 non-GAAP earnings of 93 cents per share, which missed the Zacks Consensus Estimate by 1.1%. The figure rose 3.3% year over year.HPQ’s earnings beat the Zacks Consensus Estimate in one of the trailing four quarters, missed twice and matched once, the average negative surprise being 0.83%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.HPQ’s revenues increased 1.7% year over year to $14.06 billion but marginally missed the Zacks Consensu ...